Herb-drug interactions: Focus on metabolic enzymes and transporters

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1843-1863

  Choi, Young Hee ^a   Chin, Young Won ^a   Kim, Yoon Gyoon ^b  

^a Dongguk University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Herb drug interaction; P450; Pharmacokinetics; Transporter

Indexed keywords

ALDEHYDE DEHYDROGENASE; AMIDASE; AMINE OXIDASE (FLAVIN CONTAINING); BREAST CANCER RESISTANCE PROTEIN; CARBOXYLESTERASE; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B1; CYTOCHROME P450 2B6; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 4A; DIMETHYLANILINE MONOOXYGENASE; ENZYME; EPOXIDE HYDROLASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; GLUTATHIONE; GLYCOPROTEIN P; HERBACEOUS AGENT; MULTIDRUG RESISTANCE PROTEIN 2; PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SULFOTRANSFERASE;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; GINKGO BILOBA; GINSENG; GLUCURONIDATION; GLYCYRRHIZA; GRAPE; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; LIVER METABOLISM; METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SABAL; SILYBUM MARIANUM; TEA;

ANIMALS; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HERB-DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; INTESTINES; LIVER; PHARMACOKINETICS; PLANT EXTRACTS; PLANT PREPARATIONS;

EID: 83655180989     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-1106-z     Document Type: Review

References (159)

1. D. R. Abernethy L. S. Kaminsky T. H. Dickinson 1991 Selective inhibition of warfarin metabolism by diltiazem in humans J. Pharmacol. Exp. Ther. 257 411 415 2020000 1:CAS:528:DyaK3MXitl2qs78%3D
2. I. Alfaras M. Pérez M. E. Juan G. Merino J. G. Prieto J. M. Planas A. I. Alvarez 2010 Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice J. Agric. Food Chem. 58 4523 4528 20232796 1:CAS:528:DC%2BC3cXjt1enu70%3D 10.1021/jf9042858
3. H. Amagase B. L. Petesch H. Matsuura S. Kasuga Y. Itakura 2001 Intake of garlic and its bioactive components J. Nutr. 131 955S 962S 11238796 1:CAS:528:DC%2BD3MXhvVOitbg%3D (Pubitemid 32194988)
4. G. An J. Gallegos M. E. Morris 2011 The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux Drug Metab. Dispos. 39 426 432 21139040 1:CAS:528:DC%2BC3MXivVWitb0%3D 10.1124/dmd.110.035212
5. J. Anke I. Ramzan 2004 Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.) J. Ethnopharmacol. 93 153 160 15234747 1:CAS:528:DC%2BD2cXltl2hsrw%3D 10.1016/j.jep.2004.04.009 (Pubitemid 38962400)
6. S. Beckmann-Knopp S. Rietbrock R. Weyhenmeyer R. H. Böcker K. T. Beckurts W. Lang M. Hunz U. Fuhr 2000 Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes Pharmacol. Toxicol. 86 250 256 10895987 1:CAS:528:DC%2BD3cXlsVyltbk%3D 10.1111/j.0901-9928.2000.860602.x (Pubitemid 30413400)
7. S. Bent C. Kane K. Shinohara J. Neuhaus E. S. Hudes H. Goldberg A. L. Avins 2006 Saw palmetto for benign prostatic hyperplasia N. Engl. J. Med. 354 557 566 16467543 1:CAS:528:DC%2BD28Xhtleksb0%3D 10.1056/NEJMoa053085 (Pubitemid 43209103)
8. L. Bertilsson J. A. Carrillo M. L. Dahl A. Llerena C. Alm U. Bondesson L. Lindström R. I. de la Rodriguez S. Ramos J. Benitez 1994 Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test Br. J. Clin. Pharmacol. 38 471 473 7893591 1:CAS:528:DyaK2MXis1Sgt7c%3D (Pubitemid 24344037)
9. M. Bobrowska-Hägerstrand M. Lillås L. Mrówczyñska A. Wróbel Y. Shirataki N. Motohashi H. Hägerstrand 2006 Resveratrol oligomers are potent MRP1 transport inhibitors Anticancer Res. 26 2081 2084 16827148 (Pubitemid 43989473)
10. S. S. Brill A. M. Furimsky M. N. Ho M. J. Furniss Y. Li A. G. Green W. W. Bradford C. E. Green I. M. Kapetanovic L. V. Iyer 2006 Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms J. Pharm. Pharmacol. 58 469 479 16597364 1:CAS:528:DC%2BD28XpsFKgsLk%3D 10.1211/jpp.58.4.0006
11. J. W. Budzinski B.C. Foster S. Vandenhoek J. T. Arnason 2000 An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures Phytomedicine 7 273 282 10969720 1:CAS:528: DC%2BD3cXmslSnsbs%3D 10.1016/S0944-7113(00)80044-6 (Pubitemid 30618491)
12. A. H. Burstein R. L. Horton T. Dunn R. M. Alfaro S. C. Piscitelli W. Theodore 2000 Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers Clin. Pharmacol. Ther. 68 605 612 11180020 1:CAS:528:DC%2BD3MXht1Sjs7c%3D 10.1067/mcp.2000.111530 (Pubitemid 32059986)
13. V. Butterweck M. Schmidt 2007 St. John's wort: role of active compounds for its mechanism of action and efficacy Wien. Med. Wochenschr. 157 356 361 17704987 10.1007/s10354-007-0440-8 (Pubitemid 47356264)
14. Z. Cai T. Qian R. Wong Z. Jiand 2003 Liquid chromatography-electrospray ionization mass spectrometry for metabolism and pharmacokinetic studies of ginsenoside Rg3 Anal. Chim. Acta 492 283 293 1:CAS:528:DC%2BD3sXntVyju7c%3D 10.1016/S0003-2670(03)00719-0 (Pubitemid 37101408)
15. N. B. Cech K. Tutor B. A. Doty K. Spelman M. Sasagawa G. M. Raner C. A. Wenner 2006 Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity Planta Med. 72 1372 1377 17054047 1:CAS:528:DC%2BD2sXmsFGqtg%3D%3D 10.1055/s-2006- 951718 (Pubitemid 46102390)
16. W. K. Chan A. B. Delucchi 2000 Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4 Life Sci. 67 3103 3112 11125847 1:CAS:528:DC%2BD3cXotlChur4%3D 10.1016/S0024-3205(00)00888-2
17. T. K. Chang J. Chen S. A. Benetton 2002 In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1 Drug Metab. Dispos. 30 378 384 11901090 1:CAS:528:DC%2BD38Xis1Ols7c%3D 10.1124/dmd.30.4.378 (Pubitemid 34263821)
18. Y. Chen S. Xie S. Chen S. Zeng 2008 Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9 Biochem. Pharmacol. 76 416 425 18565494 1:CAS:528:DC%2BD1cXosVOms7Y%3D 10.1016/j.bcp.2008.05.007
19. Y. W. Chin H. A. Jung Y. Liu B. N. Su J. A. Castoro W. J. Keller M. A. Pereira A. D. Kinghorn 2007 Antioxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra) J. Agric. Food Chem. 55 4691 4697 17516657 1:CAS:528:DC%2BD2sXls1SmtLk%3D 10.1021/jf0703553 (Pubitemid 46960894)
20. J. S. Choi B. C. Choi K. W. Kang 2009 Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol Pharmazie 64 49 52 19216231 1:CAS:528:DC%2BD1MXhtVOjsr8%3D
21. H. H. Chow L. L. Garland C. H. Hsu D. R. Vining W. M. Chew J. A. Miller M. Perloff J. A. Crowell D. S. Alberts 2010 Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study Cancer Prev. Res. (Phila) 3 1168 1175 1:CAS:528:DC%2BC3cXht1Gju7%2FK 10.1158/1940-6207.CAPR-09- 0155
22. L. P. Christensen 2009 Ginsenosides chemistry, biosynthesis, analysis, and potential health effects Adv. Food Nutr. Res. 55 1 99 18772102 1:CAS:528:DC%2BD1cXhsVOqsLzJ 10.1016/S1043-4526(08)00401-4
23. V. J. Chrungoo R. K. Reen K. Singh J. Singh 1997 Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity Indian J. Exp. Biol. 35 256 263 9332170 1:CAS:528:DyaK2sXjs1Ghsbg%3D (Pubitemid 28135413)
24. N. P. Clayton K. Yoshizawa G. E. Kissling L. T. Burka P. C. Chan A. Nyska 2007 Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract Exp. Toxicol. Pathol. 58 223 236 17059882 1:CAS:528:DC%2BD2sXitVCrsLk%3D 10.1016/j.etp.2006.08.002 (Pubitemid 44873076)
25. C. Colalto 2010 Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment Pharmacol. Res. 62 207 227 20399862 1:CAS:528:DC%2BC3cXosVWmsrw%3D 10.1016/j.phrs.2010.04.001
26. M. Corzo-Martínez N. Corzo M. Villamiel 2007 Biological properties of onions and garlic Trends Food Sci. Tech. 18 609 625 10.1016/j.tifs.2007.07. 011 1:CAS:528:DC%2BD2sXht1KhsL%2FN (Pubitemid 350008034)
27. V. Crespy N. Nancoz M. Oliveira J. Hau M. C. Courtet-Compondu G. Williamson 2004 Glucuronidation of the green tea catechins, (-)- epigallocatechin-3-gallate and (-)-epicatechin-3-gallate, by rat hepatic and intestinal microsomes Free Radic. Res. 38 1025 1031 15621722 1:CAS:528:DC%2BD2cXoslensL0%3D 10.1080/10715760410001728424 (Pubitemid 39341700)
28. M. Cuendet J. Guo Y. Luo S. Chen C. P. Oteham R. C. Moon R. B. van Breemen L. E. Marler J. M. Pezzuto 2010 Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice Cancer Prev. Res. (Phila) 3 221 232 1:CAS:528:DC%2BC3cXptFOisLs%3D 10.1158/1940-6207.CAPR-09-0049
29. J. G. Dausch D. W. Nixon 1990 Garlic: a review of its relationship to malignant disease Prev. Med. 19 346 361 2198557 1:CAS:528:DyaK3cXlvVCjtrY%3D 10.1016/0091-7435(90)90034-H (Pubitemid 20223121)
30. M. M. de Maat R. M. Hoetelmans t. R. A. Math E. C. van Gorp P. L. Meenhorst J. W. Mulder J. H. Beijnen 2001 Drug interaction between St John's wort and nevirapine AIDS 15 420 421 11273226 10.1097/00002030-200102160-00019 (Pubitemid 32163832)
31. R. K. Dhiman Y. K. Chawla 2005 Herbal medicines for liver diseases Dig. Dis. Sci. 50 1807 1812 16187178 1:CAS:528:DC%2BD2MXhtVektL7P 10.1007/s10620-005-2942-9 (Pubitemid 41413894)
32. R. DiCenzo M. Shelton K. Jordan C. Koval A. Forrest R. Reichman G. Morse 2003 Coadministration of milk thistle and indinavir in healthy subjects Pharmacotherapy 23 866 870 12885100 1:CAS:528:DC%2BD3sXmtVGjsbc%3D 10.1592/phco.23.7.866.32723 (Pubitemid 36875670)
33. T. Ding S. Tian Z. Zhang D. Gu Y. Chen Y. Shi Z. Sun 2001 Determination of active component in silymarin by RP-LC and LC/MS J. Pharm. Biomed. Anal. 26 155 161 11451653 1:CAS:528:DC%2BD3MXltVegt7s%3D 10.1016/S0731-7085(01)00364-8 (Pubitemid 32635293)
34. J. L. Donovan C. L. DeVane K. D. Chavin R. M. Taylor J. S. Markowitz 2003 Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers Drug Metab. Dispos. 31 519 522 12695337 10.1124/dmd.31.5.519 (Pubitemid 36444158)
35. G. K. Dresser U. I. Schwarz G. R. Wilkinson R. B. Kim 2003 Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects Clin. Pharmacol. Ther. 73 41 50 12545142 1:CAS:528:DC%2BD3sXhtlKgtrc%3D 10.1067/mcp.2003.10 (Pubitemid 36158485)
36. M. L. Dupuis M. Flego A. Molinari M. Cianfriglia 2003 Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 Tlymphoblastoid CEMrev cells HIV Med. 4 338 345 14525546 1:CAS:528:DC%2BD3sXpsVOgu78%3D 10.1046/j.1468-1293.2003.00169.x (Pubitemid 37304375)
37. D. Dürr B. Stieger G. A. Kullak-Ublick K. M. Rentsch H. C. Steinert P. J. Meier K. Fattinger 2000 St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 Clin. Pharmacol. Ther. 68 598 604 11180019 10.1067/mcp.2000.112240 (Pubitemid 32059985)
38. D. Eich-Höchli R. Oppliger K. P. Golay P. Baumann C. B. Eap 2003 Methadone maintenance treatment and St. John's Wort - a case report Pharmacopsychiatry 36 35 37 12649774 10.1055/s-2003-38090 (Pubitemid 36384633)
39. V. Fischer B. Vogels G. Maurer R. E. Tynes 1992 The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6 J. Pharmacol. Exp. Ther. 260 1355 1360 1545398 1:CAS:528:DyaK38XhvVOnt7c%3D
40. Fleming, T., PDR for herbal medicines. Thomson Reuters, New York, (2000).
41. R. J. Fontana T. M. deVries T. F. Woolf M. J. Knapp A. S. Brown L. S. Kaminsky B. K. Tang N. L. Foster R. R. Brown P. B. Watkins 1998 Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease Br. J. Clin. Pharmacol. 46 221 228 9764962 1:CAS:528:DyaK1cXmtFKmtLo%3D 10.1046/j.1365-2125.1998.00776.x (Pubitemid 28404834)
42. B. C. Foster M. S. Foster S. Vandenhoek A. Krantis J. W. Budzinski J. T. Arnason K. D. Gallicano S. Choudri 2001 An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic J. Pharm. Pharm. Sci. 4 176 184 11466175 1:CAS:528:DC%2BD3MXnsFyhtLk%3D (Pubitemid 34305609)
43. H. Fuchikami H. Satoh M. Tsujimoto S. Ohdo H. Ohtani Y. Sawada 2006 Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B Drug Metab. Dispos. 34 577 582 16415120 1:CAS:528: DC%2BD28XjtlKnsL8%3D 10.1124/dmd.105.007872
44. R. E. Gammans R. F. Mayol J. A. LaBudde 1986 Metabolism and disposition of buspirone Am. J. Med. 80 41 51 3515929 1:CAS:528:DyaL28XhvF2gtrY%3D 10.1016/0002-9343(86)90331-1 (Pubitemid 16097584)
45. B. Gaster J. Holroyd 2000 St John's wort for depression: a systematic review Arch. Intern. Med. 160 152 156 10647752 1:STN:280:DC%2BD3c7ht1akug%3D%3D 10.1001/archinte.160.2.152 (Pubitemid 30054333)
46. G. Gatti E. Perucca 1994 Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers Int. J. Clin. Pharmacol. Ther. 32 614 617 7874377 1:CAS:528:DyaK2MXivFSmsbw%3D (Pubitemid 24336552)
47. C. Gaudineau R. Beckerman S. Welbourn K. Auclair 2004 Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract Biochem. Biophys. Res. Commun. 318 1072 1078 15147983 1:CAS:528:DC%2BD2cXktV2mu7Y%3D 10.1016/j.bbrc.2004.04.139 (Pubitemid 38625885)
48. A. Geick M. Eichelbaum O. Burk 2001 Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin J. Biol. Chem. 276 14581 14587 11297522 1:CAS:528:DC%2BD3MXjs1OktL0%3D 10.1074/jbc.M010173200
49. J. C. Gorski D. R. Jones M. A. Hamman S. A. Wrighton S. D. Hall 1999 Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily Xenobiotica 29 931 944 10548453 1:CAS:528:DyaK1MXms1Ojs70%3D 10.1080/004982599238173 (Pubitemid 29454386)
50. J. C. Gorski S. M. Huang A. Pinto M. A. Hamman J. K. Hilligoss N. A. Zaheer M. Desai M. Miller S. D. Hall 2004 The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo Clin. Pharmacol. Ther. 75 89 100 14749695 10.1016/j.clpt.2003.09.013 (Pubitemid 38130121)
51. D. J. Greenblatt C. E. Wright 1993 Clinical pharmacokinetics of alprazolam. Therapeutic implications Clin. Pharmacokinet. 24 453 471 8513649 1:STN:280:DyaK3s3pt1aktg%3D%3D 10.2165/00003088-199324060-00003 (Pubitemid 23160615)
52. B. J. Gurley S. F. Gardner M. A. Hubbard D. K. Williams W. B. Gentry Y. Cui C. Y. Ang 2002 Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans Clin. Pharmacol. Ther. 72 276 287 12235448 1:CAS:528:DC%2BD38XotVSmurw%3D 10.1067/mcp.2002.126913
53. B. J. Gurley S. F. Gardner M. A. Hubbard D. K. Williams W. B. Gentry J. Carrier I. A. Khan D. J. Edwards A. Shah 2004 In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto Clin. Pharmacol. Ther. 76 428 440 15536458 10.1016/j.clpt.2004.07.007 (Pubitemid 39469867)
54. B. J. Gurley A. Swain M. A. Hubbard F. Hartsfield J. Thaden D. K. Williams W. B. Gentry Y. Tong 2008 Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo Clin. Pharmacol. Ther. 83 61 69 17495878 1:CAS:528: DC%2BD2sXhsVylt7fI 10.1038/sj.clpt.6100222
55. P. R. Gwilt C. L. Lear M. A. Tempero D. D. Birt A. C. Grandjean R. W. Ruddon D. L. Nagel 1994 The effect of garlic extract on human metabolism of acetaminophen Cancer Epidemiol. Biomarkers Prev. 3 155 160 8049637 1:CAS:528:DyaK2cXkt1Kitbw%3D (Pubitemid 24170059)
56. J. C. Harris S. L. Cottrell S. Plummer D. Lloyd 2001 Antimicrobial properties of Allium sativum (garlic) Appl. Microbiol. Biotechnol. 57 282 286 11759674 1:CAS:528:DC%2BD3MXotlahtrc%3D 10.1007/s002530100722 (Pubitemid 32972334)
57. K. He K. R. Iyer R. N. Hayes M. W. Sinz T. F. Woolf P. F. Hollenberg 1998 Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice Chem. Res. Toxicol. 11 252 259 9548795 1:CAS:528:DyaK1cXitVyrtLo%3D 10.1021/tx970192k (Pubitemid 28194348)
58. L. D. Heimark M. Gibaldi W. F. Trager R. A. O'Reilly D. A. Goulart 1987 The mechanism of the warfarin-rifampin drug interaction in humans Clin. Pharmacol. Ther. 42 388 394 3665337 1:CAS:528:DyaL1cXjtFegsQ%3D%3D 10.1038/clpt.1987.168 (Pubitemid 17165700)
59. B. H. Hellum O. G. Nilsen 2008 In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products Basic Clin. Pharmacol. Toxicol. 102 466 475 18331390 1:CAS:528:DC%2BD1cXmtVWgsLs%3D 10.1111/j.1742-7843.2008.00227.x (Pubitemid 351537792)
60. G. L. Henderson M. R. Harkey M. E. Gershwin R. M. Hackman J. S. Stern D. M. Stresser 1999 Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity Life Sci. 65 PL209 PL214 10574228 1:CAS:528:DyaK1MXlvFyqtbs%3D 10.1016/S0024-3205(99)00407-5
61. P. Jancová E. Anzenbacherová B. Papousková K. Lemr P. Luzná A. Veinlichová P. Anzenbacher V. Simánek 2007 Silybin is metabolized by cytochrome P450 2C8 in vitro Drug Metab. Dispos. 35 2035 2039 17670841 10.1124/dmd.107.016410 1:CAS:528:DC%2BD2sXht1Cnu7vE (Pubitemid 350005192)
62. C. Jia H. Shi W. Jin K. Zhang Y. Jiang M. Zhao P. Tu 2009 Metabolism of echinacoside, a good antioxidant, in rats: isolation and identification of its biliary metabolites Drug Metab. Dispos. 37 431 438 19022941 1:CAS:528: DC%2BD1MXhs1Krtr0%3D 10.1124/dmd.108.023697
63. X. Jiang K. M. Williams W. S. Liauw A. J. Ammit B. D. Roufogalis C. C. Duke R. O. Day A. J. McLachlan 2004 Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects Br. J. Clin. Pharmacol. 57 592 599 15089812 1:CAS:528:DC%2BD2cXksF2ktbw%3D 10.1111/j.1365-2125.2003.02051.x (Pubitemid 38582179)
64. J. Jodoin M. Demeule R. Beliveau 2002 Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols Biochim. Biophys. Acta 1542 149 159 11853888 1:CAS:528:DC%2BD38Xhtlersbg%3D 10.1016/S0167-4889(01) 00175-6
65. A. Johne J. Schmider J. Brockmöller A. M. Stadelmann E. Störmer S. Bauer G. Scholler M. Langheinrich I. Roots 2002 Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum) J. Clin. Psychopharmacol. 22 46 54 11799342 1:CAS:528:DC%2BD38Xht1yku7s%3D 10.1097/00004714-200202000-00008 (Pubitemid 34101292)
66. M. E. Juan E. González-Pons J. M. Planas 2010 Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats J. Nutr. 140 489 495 20089784 1:CAS:528:DC%2BC3cXnsFKhsbo%3D 10.3945/jn.109.114959
67. S. Kasper M. Gastpar W. E. Müller H. P. Volz A. Dienel M. Kieser H. J. Möller 2008 Efficacy of St. John's wort extract WS® 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials Eur. Arch. Psychiatry Clin. Neurosci. 258 59 63 18084790 1:STN:280:DC%2BD1c%2FptlWrtQ%3D%3D 10.1007/s00406-007-0779-2 (Pubitemid 351208250)
68. U. M. Kent M. Aviram M. Rosenblat P. F. Hollenberg 2002 The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9 Drug Metab. Dispos. 30 709 715 12019199 1:CAS:528: DC%2BD38XktFSlsbc%3D 10.1124/dmd.30.6.709 (Pubitemid 34579106)
69. A. E. Kim J. M. Dintaman D. S. Waddell J. A. Silverman 1998 Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein J. Pharmacol. Exp. Ther. 286 1439 1445 9732409 1:CAS:528:DyaK1cXmt1GqsLY%3D (Pubitemid 29135560)
70. D. H. Kim Y. H. Jin J. B. Park K. Kobashi 1994 Silymarin and its components are inhibitors of beta-glucuronidase Biol. Pharm. Bull. 17 443 445 8019514 1:CAS:528:DyaK2cXkt1Krt74%3D 10.1248/bpb.17.443 (Pubitemid 24155153)
71. H. J. Kim Y. J. Chun J. D. Park S. I. Kim J. K. Roh T. C. Jeong 1997 Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition Planta Med. 63 415 418 9342944 1:CAS:528:DyaK2sXmt12gsL0%3D 10.1055/s-2006-957724 (Pubitemid 27399978)
72. Kinghorn, A. D. and Compadre, C. M., Less common high potency sweeteners. In AlternatiVe Sweeteners, Third Editions Revised and Expanded; O'Brien Nabors, L. (Ed.). Marcel Dekker, New York, pp. 209-231, (2001).
73. V. Kren J. Ulrichová P. Kosina D. Stevenson P. Sedmera V. Prikrylová P. Halada V. Simánek 2000 Chemoenzymatic preparation of silybin beta-glucuronides and their biological evaluation Drug Metab. Dispos. 28 1513 1517 11095591 1:CAS:528:DC%2BD3cXos1Srs7k%3D
74. F. Kvasnicka B. Bíba R. Sevcík M. Voldrich J. Krátká 2003 Analysis of the active components of silymarin J. Chromatogr. A 990 239 245 12685603 1:CAS:528:DC%2BD3sXhvFKjtr0%3D 10.1016/S0021-9673(02)01971-4 (Pubitemid 36293880)
75. E. Kyo N. Uda S. Kasuga Y. Itakura 2001 Immunomodulatory effects of aged garlic extract J. Nutr. 131 1075S 1079S 11238820 1:CAS:528:DC%2BD3MXhvVOhsr4%3D (Pubitemid 32195011)
76. H. W. Leber S. Knauff 1976 Influence of silymarin on drug metabolizing enzymes in rat and man Arzneimittelforschung 26 1603 1605 1036961 1:CAS:528:DyaE28XltFKktL0%3D
77. V. Lebot J. Lévesque 1989 The origin and distribution of kava (Piper methysticum Forst. f. and Piper wichmannii C. DC., Piperace-ae): a phytochemical approach Allertonia 5 223 280
78. L. S. Lee A. S. Andrade C. Flexner 2006 Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects Clin. Infect. Dis. 43 1052 1059 16983620 1:CAS:528:DC%2BD28XhtFKiu7bM 10.1086/507894 (Pubitemid 44631108)
79. S. T. Lim K. Dragull C. S. Tang H. C. Bittenbender J. T. Efird P. V. Nerurkar 2007 Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats Toxicol. Sci. 97 214 221 17329236 1:CAS:528:DC%2BD2sXlvVKjtLs%3D 10.1093/toxsci/kfm035 (Pubitemid 47072170)
80. M. C. Lin E. J. Wang C. Patten M. J. Lee F. Xiao K. R. Reuhl C. S. Yang 1996 Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice J. Biochem. Toxicol. 11 11 20 8806047 1:CAS:528:DyaK28XjvFaqs78%3D 10.1002/(SICI)1522-7146(1996)11:1<11::AID- JBT2>3.0.CO;2-Y (Pubitemid 126803502)
81. D. Lorenz W. H. Mennicke W. Behrendt 1982 Untersuchungen zur Elimination von Silymarin bei cholezystektomierten Patienten Planta Med. 45 216 223 10.1055/s-2007-971376 (Pubitemid 12035793)
82. H. Lu X. Meng C. Li S. Sang C. Patten S. Sheng J. Hong N. Bai B. Winnik C. T. Ho C. S. Yang 2003 Glucuronides of tea catechins: enzymology of biosynthesis and biological activities Drug Metab. Dispos. 31 452 461 12642472 1:CAS:528:DC%2BD3sXisFeit70%3D 10.1124/dmd.31.4.452 (Pubitemid 36378523)
83. J. M. Lü Q. Yao C. Chen 2009 Ginseng compounds: an update on their molecular mechanisms and medical applications Curr. Vasc. Pharmacol. 7 293 302 19601854 10.2174/157016109788340767
84. P. I. Mackenzie P. A. Gregory D. A. Gardner-Stephen R. H. Lewinsky B. R. Jorgensen T. Nishiyama W. Xie A. Radominska-Pandya 2003 Regulation of UDP glucuronosyltransferase genes Curr. Drug Metab. 4 249 257 12769669 1:CAS:528:DC%2BD3sXktV2ksL0%3D 10.2174/1389200033489442 (Pubitemid 36656482)
85. I. Mai E. Störmer S. Bauer H. Krüger K. Budde I. Roots 2003 Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients Nephrol. Dial. Transplant. 18 819 822 12637655 1:CAS:528:DC%2BD3sXit1yqs78%3D 10.1093/ndt/gfg002 (Pubitemid 36432268)
86. P. T. Manyike E. D. Kharasch T. F. Kalhorn J. T. Slattery 2000 Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation Clin. Pharmacol. Ther. 67 275 282 10741631 1:CAS:528:DC%2BD3cXis1Ghtrs%3D 10.1067/mcp.2000.104736 (Pubitemid 30176386)
87. J. S. Markowitz C. L. DeVane D. W. Boulton S. W. Carson Z. Nahas S. C. Risch 2000 Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers Life Sci. 66 PL133 PL139 10698361 1:CAS:528:DC%2BD3cXmvFOjug%3D%3D 10.1016/S0024-3205(99)00659-1
88. J. S. Markowitz J. L. Donovan C. Lindsay DeVane L. Sipkes K. D. Chavin 2003 Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers J. Clin. Psychopharmacol. 23 576 581 14624188 1:CAS:528:DC%2BD3sXptVCntLg%3D 10.1097/01.jcp.0000095340.32154.c6 (Pubitemid 37443189)
89. J. S. Markowitz J. L. Donovan C. L. Devane R. M. Taylor Y. Ruan J. S. Wang K. D. Chavin 2003 Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers Clin. Pharmacol. Ther. 74 536 542 14663456 1:CAS:528:DC%2BD3sXps1ertb0%3D 10.1016/j.clpt.2003. 08.010 (Pubitemid 37521997)
90. J. S. Markowitz C. L. Devane K. D. Chavin R. M. Taylor Y. Ruan J. L. Donovan 2003 Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers Clin. Pharmacol. Ther. 74 170 177 12891227 1:CAS:528:DC%2BD3sXlvVCrt7Y%3D 10.1016/S0009-9236(03)00148-6 (Pubitemid 36951814)
91. J. M. Mathews A. S. Etheridge J. L. Valentine S. R. Black D. P. Coleman P. Patel J. So L. T. Burka 2005 Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. Drug Metab. Dispos. 33 1555 1563 16033948 1:CAS:528:DC%2BD2MXhtVKrurfN 10.1124/dmd.105.004317 (Pubitemid 41324005)
92. R. H. Mathijssen J. Verweij P. de Bruijn W. J. Loos A. Sparreboom 2002 Effects of St. John's wort on irinotecan metabolism J. Natl. Cancer Inst. 94 1247 1249 12189228 1:CAS:528:DC%2BD38XntVyjsL8%3D (Pubitemid 34993875)
93. A. Matthias E. M. Gillam K. G. Penman N. J. Matovic K. M. Bone J. J. De Voss R. P. Lehmann 2005 Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes Chem. Biol. Interact. 155 62 70 15885678 1:CAS:528:DC%2BD2MXlsFGisbw%3D 10.1016/j.cbi.2005.04.003 (Pubitemid 40835990)
94. S. McRae 1996 Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng CMAJ 155 293 295 8705908 1:STN:280:DyaK28zhs1yrtw%3D%3D (Pubitemid 26268001)
95. M. E. Mohamed R. F. Frye 2011 Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies Planta Med. 77 311 321 21049395 1:CAS:528:DC%2BC3MXkvVOmsr4%3D 10.1055/s-0030-1250457
96. M. E. Mohamed R. F. Frye 2011 Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities Drug Metab. Dispos. 39 1522 1528 21632963 10.1124/dmd.111.039602
97. M. F. Mohamed R. F. Frye 2010 Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids Drug Metab. Dispos. 38 270 275 19889883 1:CAS:528:DC%2BC3cXhsVSmsr8%3D 10.1124/dmd.109.030080
98. M. F. Mohamed T. Tseng R. F. Frye 2010 Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity Xenobiotica 40 663 669 20666626 1:CAS:528:DC%2BC3cXhtFCrtL7J 10.3109/00498254.2010.505669
99. A. Moon S. H. Kim 1997 Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats Planta Med. 63 115 119 9140223 1:CAS:528:DyaK2sXislektLg%3D 10.1055/s-2006-957625 (Pubitemid 27196076)
100. T. Nabekura T. Yamaki K. Ueno S. Kitagawa 2008 Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals Cancer Chemother. Pharmacol. 62 867 873 18204840 1:CAS:528:DC%2BD1cXht1CjtLvL 10.1007/s00280-007-0676-4
101. I. A. Najar B. S. Sachin S. C. Sharma N. K. Satti K. A. Suri R. K. Johri 2010 Modulation of P-glycoprotein ATPase activity by some phytoconstituents Phytother. Res. 24 454 458 19653312 1:CAS:528:DC%2BC3cXktlyks7k%3D 10.1002/ptr.2951
102. A. Nebel B. J. Schneider R. K. Baker D. J. Kroll 1999 Potential metabolic interaction between St. John's wort and theophylline Ann. Pharmacother. 33 502 10332544 1:STN:280:DyaK1M3msV2nug%3D%3D 10.1345/aph.18252 (Pubitemid 29215819)
103. M. I. Netsch H. Gutmann S. Luescher S. Brill C. B. Schmidlin M. H. Kreuter J. Drewe 2005 Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality Planta Med. 71 135 141 15729621 1:CAS:528:DC%2BD2MXivFGlsLw%3D 10.1055/s-2005-837780 (Pubitemid 40363556)
104. M. I. Netsch H. Gutmann C. B. Schmidlin C. Aydogan J. Drewe 2006 Induction of CYP1A by green tea extract in human intestinal cell lines Planta Med. 72 514 520 16773535 1:CAS:528:DC%2BD28XlsFWksLk%3D 10.1055/s-2006-931537 (Pubitemid 43844678)
105. H. Nguyen S. Zhang M. E. Morris 2003 Effect of flavonoids on MRP1-mediated transport in Panc-1 cells J. Pharm. Sci. 92 250 257 12532374 1:CAS:528:DC%2BD3sXhtFantrk%3D 10.1002/jps.10283 (Pubitemid 36169297)
106. T. D. Nguyen P. H. Villard A. Barlatier A. E. Elsisi E. Jouve N. M. Duc C. Sauze A. Durand B. Lacarelle 2000 Panax vietnamensis protects mice against carbon tetrachloride-induced hepatotoxicity without any modification of CYP2E1 gene expression Planta Med. 66 714 719 11199127 1:CAS:528:DC%2BD3MXis12gug%3D%3D 10.1055/s-2000-9603 (Pubitemid 32038926)
107. M. Nishikawa N. Ariyoshi A. Kotani I. Ishii H. Nakamura H. Nakasa M. Ida H. Nakamura N. Kimura M. Kimura A. Hasegawa F. Kusu S. Ohmori K. Nakazawa M. Kitada 2004 Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam Drug Metab. Pharmacokinet. 19 280 289 15499196 1:CAS:528:DC%2BD2cXns1ynsrc%3D 10.2133/dmpk.19.280
108. R. S. Obach 2000 Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression J. Pharmacol. Exp. Ther. 294 88 95 10871299 1:CAS:528: DC%2BD3cXksFyht7s%3D (Pubitemid 30434674)
109. R. A. Okerholm D. L. Weiner R. H. Hook B. J. Walker G. A. Leeson S. A. Biedenbach M. J. Cawein T. D. Dusebout G. J. Wright M. Myers V. Schindler C. E. Cook 1981 Bioavailability of terfenadine in man Biopharm. Drug Dispos. 2 185 190 6113858 1:CAS:528:DyaL3MXksleisLk%3D 10.1002/bdd.2510020211 (Pubitemid 11095227)
110. E. J. Oliveira D. G. Watson 2000 In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9 microsomes FEBS Lett. 471 1 6 10760502 1:CAS:528:DC%2BD3cXit1Wgtbk%3D 10.1016/S0014-5793(00)01355-7 (Pubitemid 30173282)
111. M. Paolini L. Pozzetti A. Sapone G. Cantelli-Forti 1998 Effect of licorice and glycyrrhizin on murine liver CYPdependent monooxygenases Life Sci. 62 571 582 9464470 1:CAS:528:DyaK1cXitVaitg%3D%3D 10.1016/S0024-3205(97)01154-5 (Pubitemid 28050076)
112. M. Pirmohamed D. Williams S. Madden E. Templeton B. K. Park 1995 Metabolism and bioactivation of clozapine by human liver in vitro J. Pharmacol. Exp. Ther. 272 984 990 7891353 1:CAS:528:DyaK2MXktl2ksr4%3D
113. S. C. Piscitelli A. H. Burstein D. Chaitt R. M. Alfaro J. Falloon 2000 Indinavir concentrations and St John's wort Lancet 355 547 548 10683007 1:CAS:528:DC%2BD3cXhs1elsbs%3D 10.1016/S0140-6736(99)05712-8 (Pubitemid 30088677)
114. S. C. Piscitelli E. Formentini A. H. Burstein R. Alfaro S. Jagannatha J. Falloon 2002 Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers Pharmacotherapy 22 551 556 12013352 1:CAS:528: DC%2BD38XktFWks7c%3D 10.1592/phco.22.8.551.33205 (Pubitemid 34464940)
115. B. Piver F. Berthou Y. Dreano D. Lucas 2001 Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components Toxicol. Lett. 125 83 91 11701226 1:CAS:528:DC%2BD3MXotFSmu74%3D 10.1016/S0378-4274(01)00418-0 (Pubitemid 33043758)
116. B. Piver F. Berthou Y. Dreano D. Lucas 2003 Differential inhibition of human cytochrome P450 enzymes by epsilonviniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages Life Sci. 73 1199 1213 12818727 1:CAS:528:DC%2BD3sXks1ejuro%3D 10.1016/S0024-3205(03) 00420-X (Pubitemid 36733564)
117. M. G. Quaglia E. Bossù E. Donati G. Mazzanti A. Brandt 1999 Determination of silymarine in the extract from the dried silybum marianum fruits by high performance liquid chromatography and capillary electrophoresis J. Pharm. Biomed. Anal. 19 435 442 10704109 1:CAS:528:DyaK1MXht1Chu78%3D 10.1016/S0731-7085(98)00231-3 (Pubitemid 29073501)
118. A. E. Rettie K. R. Korzekwa K. L. Kunze R. F. Lawrence A. C. Eddy T. Aoyama H. V. Gelboin F. J. Gonzalez W. F. Trager 1992 Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions Chem. Res. Toxicol. 5 54 59 1581537 1:CAS:528:DyaK38Xjtl2msw%3D%3D 10.1021/tx00025a009
119. C. A. Roby G. D. Anderson E. Kantor D. A. Dryer A. H. Burstein 2000 St John's Wort: effect on CYP3A4 activity Clin. Pharmacol. Ther. 67 451 457 10824623 1:CAS:528:DC%2BD3cXktVCmsbk%3D 10.1067/mcp.2000.106793 (Pubitemid 30327483)
120. S. M. Ross 2008 Milk thistle (Silybum marianum): an ancient botanical medicine for modern times Holist. Nurs. Pract. 22 299 300 18758279
121. R. Schandalik G. Gatti E. Perucca 1992 Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients Arzneimittelforschung 42 964 968 1329780 1:STN:280: DyaK3s%2FjvV2ksw%3D%3D
122. A. H. Schinkel E. Wagenaar L. van Deemter C. A. Mol P. Borst 1995 Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A J. Clin. Invest. 96 1698 1705 7560060 1:CAS:528:DyaK2MXosFyhsLY%3D 10.1172/JCI118214
123. H. U. Schulz M. Schürer G. Krumbiegel W. Wächter R. Weyhenmeyer G. Seidel 1995 The solubility and bioequivalence of silymarin preparations Arzneimittelforschung 45 61 64 7893272 1:CAS:528:DyaK2MXktFWms7o%3D
124. I. Sinescu P. Geavlete R. Multescu C. Gangu F. Miclea I. Coman I. Ioiart V. Ambert T. Constantin B. Petrut B. Feciche 2011 Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia Urol. Int. 86 284 289 21304222 10.1159/000322645
125. U. P. Singh B. Prithiviraj B. K. Sarma M. Singh A. B. Ray 2001 Role of garlic (Allium sativum L.) in human and plant diseases Indian J. Exp. Biol. 39 310 322 11491574 1:CAS:528:DC%2BD3MXjt1Wjurk%3D (Pubitemid 32663152)
126. Y. N. Singh N. N. Singh 2002 Therapeutic potential of kava in the treatment of anxiety disorders CNS Drugs 16 731 743 12383029 10.2165/00023210-200216110-00002 (Pubitemid 35252722)
127. J. Sonoda W. Xie J. M. Rosenfeld J. L. Barwick P. S. Guzelian R. M. Evans 2002 Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR) Proc. Natl. Acad. Sci. U. S. A. 99 13801 13806 12370413 1:CAS:528:DC%2BD38XotVKmtLY%3D 10.1073/pnas.212494599 (Pubitemid 35215461)
128. V. Spaldin S. Madden D. A. Adams R. J. Edwards D. S. Davies B. K. Park 1995 Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe Drug Metab. Dispos. 23 929 934 8565783 1:CAS:528:DyaK2MXot1Wnu78%3D
129. A. Sparreboom M. C. Cox M. R. Acharya W. D. Figg 2004 Herbal remedies in the United States: potential adverse interactions with anticancer agents J. Clin. Oncol. 22 2489 2503 15197212 1:CAS:528:DC%2BD2cXpsVWksrs%3D 10.1200/JCO.2004.08.182 (Pubitemid 41115408)
130. C. Sridar T. C. Goosen U. M. Kent J. A. Williams P. F. Hollenberg 2004 Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases Drug Metab. Dispos. 32 587 594 15155549 1:CAS:528:DC%2BD2cXktlOgtrw%3D 10.1124/dmd.32.6.587 (Pubitemid 38668150)
131. L. J. Standish K. B. Greene S. Bain C. Reeves F. Sanders R. C. Wines P. Turet J. G. Kim C. Calabrese 2001 Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status AIDS Care 13 197 208 11304425 1:STN:280:DC%2BD3MzisFWrug%3D%3D 10.1080/095401201300059759 (Pubitemid 32319884)
132. K. Sugimoto M. Ohmori S. Tsuruoka K. Nishiki A. Kawaguchi K. Harada M. Arakawa K. Sakamoto M. Masada I. Miyamori A. Fujimura 2001 Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin Clin. Pharmacol. Ther. 70 518 524 11753267 1:CAS:528:DC%2BD38XmtVCkuw%3D%3D 10.1067/mcp.2001.120025 (Pubitemid 34008408)
133. X. Y. Sun C. A. Plouzek J. P. Henry T. T. Wang J. M. Phang 1998 Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells Cancer Res. 58 2379 2384 9622078 1:CAS:528:DyaK1cXjs12qsrs%3D (Pubitemid 28252698)
134. J. Tang J. Sun Y. Zhang L. Li F. Cui Z. He 2007 Herbdrug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats Food Chem. Toxicol. 45 2441 2445 17681658 1:CAS:528:DC%2BD2sXht1ahs77O 10.1016/j.fct.2007.05.023 (Pubitemid 47600451)
135. M. Tierra 2007 Echinacea: an effective alternative to antibiotics J. Herb. Pharmacother. 7 79 89 18285309 (Pubitemid 351146708)
136. F. Toselli A. Matthias E. M. Gillam 2009 Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine Life Sci. 85 97 106 19427870 1:CAS:528:DC%2BD1MXnslynu70%3D 10.1016/j.lfs.2009.04.023
137. J. H. Tu Y. J. He Y. Chen L. Fan W. Zhang Z. R. Tan Y. F. Huang D. Guo D. L. Hu D. Wang Z. Hong-Hao 2010 Effect of glycyrrhizin on the activity of CYP3A enzyme in humans Eur. J. Clin. Pharmacol. 66 805 810 20393696 1:CAS:528:DC%2BC3cXptVaiurk%3D 10.1007/s00228-010-0814-5
138. M. Unger U. Holzgrabe W. Jacobsen C. Cummins L. Z. Benet 2002 Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava) Planta Med. 68 1055 1058 12494328 1:CAS:528:DC%2BD3sXlt1KgsQ%3D%3D 10.1055/s-2002-36360 (Pubitemid 36140306)
139. K. van de Wetering A. Burkon W. Feddema A. Bot H. de Jonge V. Somoza P. Borst 2009 Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol Mol. Pharmacol. 75 876 885 19114588 10.1124/mol.108.052019 1:CAS:528:DC%2BD1MXktVSlu74%3D
140. E. M. van der Logt H. M. Roelofs F. M. Nagengast W. H. Peters 2003 Induction of rat hepatic and intestinal UDPglucuronosyltransferases by naturally occurring dietary anticarcinogens Carcinogenesis 24 1651 1656 12869420 10.1093/carcin/bgg117 (Pubitemid 37304670)
141. N. P. van Erp S. D. Baker M. Zhao M. A. Rudek H. J. Guchelaar J. W. Nortier A. Sparreboom H. Gelderblom 2005 Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan Clin. Cancer Res. 11 7800 7806 16278402 10.1158/1078-0432.CCR-05-1288 1:CAS:528:DC%2BD2MXhtF2isL7F (Pubitemid 41611624)
142. K. Venkatakrishnan L. L. Von Moltke D. J. Greenblatt 1999 Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs J. Clin. Pharmacol. 39 567 577 10354960 1:CAS:528:DC%2BD3cXivFahsA%3D%3D 10.1177/00912709922008173 (Pubitemid 30629036)
143. R. Venkataramanan V. Ramachandran B. J. Komoroski S. Zhang P. L. Schiff S. C. Strom 2000 Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures Drug Metab. Dispos. 28 1270 1273 11038151 1:CAS:528: DC%2BD3cXnsFOlsL4%3D
144. L. P. Volak M. H. Court 2010 Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6 Xenobiotica 40 306 318 20196639 1:CAS:528:DC%2BC3cXksVelt74%3D 10.3109/00498251003596817
145. H. P. Volz M. Kieser 1997 Kava-kava extract WS® 1490 versus placebo in anxiety disorders-a randomized placebocontrolled 25-week outpatient trial Pharmacopsychiatry 30 1 5 9065962 1:STN:280:DyaK2s3hvVGhtw%3D%3D 10.1055/s-2007-979474 (Pubitemid 27083460)
146. L. L. von Moltke J. L. Weemhoff E. Bedir I. A. Khan J. S. Harmatz P. Goldman D. J. Greenblatt 2004 Inhibition of human cytochromes P450 by components of Ginkgo biloba J. Pharm. Pharmacol. 56 1039 1044 10.1211/0022357044021 1:CAS:528:DC%2BD2cXntFeisbc%3D (Pubitemid 39140060)
147. R. W. Wang L. Liu H. Cheng 1996 Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine Drug Metab. Dispos. 24 786 791 8818577 1:CAS:528:DyaK28XktlSnu7k%3D (Pubitemid 26244222)
148. Z. Wang J. C. Gorski M. A. Hamman S. M. Huang L. J. Lesko S. D. Hall 2001 The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity Clin. Pharmacol. Ther. 70 317 326 11673747 1:STN:280: DC%2BD3MrmslShtw%3D%3D (Pubitemid 33022472)
149. R. Weyhenmeyer H. Mascher J. Birkmayer 1992 Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay Int. J. Clin. Pharmacol. Ther. Toxicol. 30 134 138 1572758 1:STN:280: DyaK383kt1Sgsw%3D%3D
150. D. Williams J. Feely 2002 Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors Clin. Pharmacokinet. 41 343 370 12036392 1:CAS:528:DC%2BD38Xlt1Gjtbc%3D 10.2165/00003088-200241050-00003 (Pubitemid 34713089)
151. J. A. Williams B. J. Ring V. E. Cantrell K. Campanale D. R. Jones S. D. Hall S. A. Wrighton 2002 Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes Drug Metab. Dispos. 30 1266 1273 12386134 1:CAS:528:DC%2BD38XotFyku7g%3D 10.1124/dmd.30.11.1266 (Pubitemid 35265835)
152. K. Woelkart K. Linde R. Bauer 2008 Echinacea for preventing and treating the common cold Planta Med. 74 633 637 18186015 1:CAS:528:DC%2BD1cXnsF2gt7s%3D 10.1055/s-2007-993766 (Pubitemid 351846777)
153. D. Wu A. I. Cederbaum 2005 Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1 Toxicol. Appl. Pharmacol. 207 70 76 16019049 10.1016/j.taap.2005.01.057 1:CAS:528:DC%2BD2MXpvFejtLY%3D (Pubitemid 41265498)
154. Y. Z. Xiang H. C. Shang X. M. Gao B. L. Zhang 2008 A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials Phytother. Res. 22 851 858 18567057 10.1002/ptr.2384
155. L. Yang Y. Deng S. Xu X. Zeng 2007 In vivo pharmacokinetic and metabolism studies of ginsenoside Rd J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 854 77 84 17526438 1:CAS:528:DC%2BD2sXntFygsbc%3D 10.1016/j.jchromb.2007.04.014 (Pubitemid 46962368)
156. X. Y. Yu S. G. Lin Z. W. Zhou X. Chen J. Liang X. Q. Yu B. Chowbay J. Y. Wen W. Duan E. Chan X. T. Li J. Cao C. G. Li C. C. Xue S. F. Zhou 2007 Role of Pglycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of Glycyrrhiza glabra Pharm. Res. 24 1668 1690 17551811 1:CAS:528:DC%2BD2sXosVKgtrg%3D 10.1007/s11095-007-9297-1 (Pubitemid 47206618)
157. S. Zhang M. E. Morris 2003 Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J. Pharmacol. Exp. Ther. 304 1258 1267 12604704 1:CAS:528:DC%2BD3sXit1eisL0%3D 10.1124/jpet.102.044412 (Pubitemid 36254439)
158. L. Zou M. R. Harkey G. L. Henderson 2002 Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity Life Sci. 71 1579 1589 12127912 1:CAS:528:DC%2BD38XlsVerur4%3D 10.1016/S0024-3205(02)01913-6 (Pubitemid 34808718)
159. R. Zuber M. Modrianský Z. Dvorák P. Rohovský J. Ulrichová V. Simánek P. Anzenbacher 2002 Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities Phytother. Res. 16 632 638 12410543 1:CAS:528:DC%2BD38XpsFKns7w%3D 10.1002/ptr.1000 (Pubitemid 35334183)